Skip to main content
Tentative approval granted to Mylan generic for lung cancer drug
8/30/2019

The FDA granted tentative approval for Mylan's drug candidate pemetrexed, a generic version of Eli Lilly and Co.'s Alimta, used to treat lung cancer, but it cannot be sold until the expiration of US patents for Alimta.

Full Story: